BIORESTORATIVE THERAPIES, INC. (BRTX) Net income 2016–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$14.2MFY2025 · since FY2016: -$8.6M → -$14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.2M | -58.6% |
| FY2024 | -$9.0M | +13.8% |
| FY2023 | -$10.4M | +21.2% |
| FY2022 | -$13.2M | +70.2% |
| FY2021 | -$44.3M | -293.0% |
| FY2020 | -$11.3M | +23.0% |
| FY2019 | -$14.6M | -17.0% |
| FY2018 | -$12.5M | -32.5% |
| FY2017 | -$9.4M | -9.4% |
| FY2016 | -$8.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net marginBRTX Gross profitBRTX Gross marginBRTX Operating incomeBRTX Operating marginBRTX Operating cash flowBRTX Free cash flowBRTX Capital expendituresBRTX Return on equityBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Total liabilitiesBRTX Shareholders’ equityBRTX overview →